C9ORF82 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.101600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.879000E-01
Normal-vs-Stage2
2.640000E-01
Normal-vs-Stage3
1.612680E-04
Normal-vs-Stage4
8.837600E-01
Stage1-vs-Stage2
1.167350E-01
Stage1-vs-Stage3
2.097600E-02
Stage1-vs-Stage4
8.993800E-01
Stage2-vs-Stage3
2.230400E-04
Stage2-vs-Stage4
1.365150E-01
Stage3-vs-Stage4
1.065000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.807800E-01
Normal-vs-AfricanAmerican
9.253800E-01
Normal-vs-Asian
1.855820E-01
Caucasian-vs-AfricanAmerican
1.899780E-01
Caucasian-vs-Asian
7.866200E-01
AfricanAmerican-vs-Asian
2.906800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.382800E-01
Normal-vs-Female
2.895600E-01
Male-vs-Female
9.658000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.837300E-03
Normal-vs-Age(41-60Yrs)
4.086000E-01
Normal-vs-Age(61-80Yrs)
2.862400E-01
Normal-vs-Age(81-100Yrs)
2.984400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.258200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.142200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.466600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.630000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.562800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.697800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.156630E-01
Normal-vs-Daily Drinker
2.397400E-01
Normal-vs-Weekly Drinker
4.798400E-02
Normal-vs-Occasional Drinker
1.873390E-01
Normal-vs-Social Drinker
1.741360E-01
Non Drinker-vs-Daily Drinker
9.137800E-01
Non Drinker-vs-Weekly Drinker
2.389000E-01
Non Drinker-vs-Occasional Drinker
3.564400E-01
Non Drinker-vs-Social Drinker
7.632400E-01
Daily Drinker-vs-Weekly Drinker
3.031600E-01
Daily Drinker-vs-Occasional Drinker
4.345000E-01
Daily Drinker-vs-Social Drinker
8.769400E-01
Weekly Drinker-vs-Occasional Drinker
1.213830E-01
Weekly Drinker-vs-Social Drinker
2.097400E-01
Occasional Drinker-vs-Social Drinker
5.363800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.602380E-01
Normal-vs-Grade 2
8.842000E-02
Normal-vs-Grade 3
1.727830E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.820600E-01
Grade 1-vs-Grade 3
6.032800E-01
Grade 1-vs-Grade 4
1.602380E-01
Grade 2-vs-Grade 3
8.738400E-01
Grade 2-vs-Grade 4
8.842000E-02
Grade 3-vs-Grade 4
1.727830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.780170E-03
Normal-vs-NonDiabetic
2.076400E-01
Diabetic-vs-NonDiabetic
3.454600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.182300E-02
Normal-vs-NoPancreatitis
2.770800E-01
Pancreatitis-vs-NoPancreatitis
3.398100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.622800E-01
Normal-vs-N1
2.253600E-01
N0-vs-N1
2.164400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.064000E-01
Normal-vs-TP53-NonMutant
7.001000E-01
TP53-Mutant-vs-TP53-NonMutant
2.448200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
